{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T04:41:45.648956+00:00","published_at":"2026-10-16T13:53:12.75153+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:7:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:charles-baum-m-d-ph-d","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Charles Baum, M.D., Ph.D.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:8:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:derek-dirocco-ph-d","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Derek DiRocco, Ph.D.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:9:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:ivana-magovevic-liebisch-ph-d-j-d","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Ivana Magovevic-Liebisch, Ph.D., J.D.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:10:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:kristina-masson-ph-d-m-b-a","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Kristina Masson, Ph.D., M.B.A.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:11:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:michael-tomsicek-m-b-a","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Michael Tomsicek, M.B.A.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:12:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:peter-blume-jensen-m-d-ph-d","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Peter Blume-Jensen, M.D., Ph.D.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:13:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:santhosh-palani-ph-d-c-f-a","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Santhosh Palani, Ph.D., CFA","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:14:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"seat_on","from_id":"alpha:person:sharon-shacham-ph-d-m-b-a","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Sharon Shacham, Ph.D., M.B.A.","to_label":"Acrivon Therapeutics, Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"committee_of","from_id":"alpha:committee:acrivon-therapeutics-inc:audit","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Audit","to_label":"Acrivon Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:chairs:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15:committee:acrivon-therapeutics-inc:audit","relationship_type":"chairs","from_id":"alpha:person:michael-tomsicek-m-b-a","to_id":"alpha:committee:acrivon-therapeutics-inc:audit","from_label":"Michael Tomsicek, M.B.A.","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:member_of:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15:committee:acrivon-therapeutics-inc:audit","relationship_type":"member_of","from_id":"alpha:person:derek-dirocco-ph-d","to_id":"alpha:committee:acrivon-therapeutics-inc:audit","from_label":"Derek DiRocco, Ph.D.","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"committee_of","from_id":"alpha:committee:acrivon-therapeutics-inc:compensation","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Compensation","to_label":"Acrivon Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:chairs:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19:committee:acrivon-therapeutics-inc:compensation","relationship_type":"chairs","from_id":"alpha:person:charles-baum-m-d-ph-d","to_id":"alpha:committee:acrivon-therapeutics-inc:compensation","from_label":"Charles Baum, M.D., Ph.D.","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:member_of:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19:committee:acrivon-therapeutics-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:santhosh-palani-ph-d-c-f-a","to_id":"alpha:committee:acrivon-therapeutics-inc:compensation","from_label":"Santhosh Palani, Ph.D., CFA","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23:company:470d407f-5f6c-4739-98b3-489250171379","relationship_type":"committee_of","from_id":"alpha:committee:acrivon-therapeutics-inc:nominating-governance","to_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","from_label":"Nominating/Governance","to_label":"Acrivon Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:chairs:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23:committee:acrivon-therapeutics-inc:nominating-governance","relationship_type":"chairs","from_id":"alpha:person:santhosh-palani-ph-d-c-f-a","to_id":"alpha:committee:acrivon-therapeutics-inc:nominating-governance","from_label":"Santhosh Palani, Ph.D., CFA","to_label":"Nominating/Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]},{"relationship_id":"alpha:relationship:member_of:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23:committee:acrivon-therapeutics-inc:nominating-governance","relationship_type":"member_of","from_id":"alpha:person:charles-baum-m-d-ph-d","to_id":"alpha:committee:acrivon-therapeutics-inc:nominating-governance","from_label":"Charles Baum, M.D., Ph.D.","to_label":"Nominating/Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23","evidence_ids":["alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284"]}]},"claims":[{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:7","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-baum-m-d-ph-d","object_label":"Charles Baum, M.D., Ph.D.","object_source_name_forms":[],"value":"Charles Baum, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-baum-m-d-ph-d","name":"Charles Baum, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:8","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:derek-dirocco-ph-d","object_label":"Derek DiRocco, Ph.D.","object_source_name_forms":[],"value":"Derek DiRocco, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:derek-dirocco-ph-d","name":"Derek DiRocco, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:9","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ivana-magovevic-liebisch-ph-d-j-d","object_label":"Ivana Magovevic-Liebisch, Ph.D., J.D.","object_source_name_forms":[],"value":"Ivana Magovevic-Liebisch, Ph.D., J.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ivana-magovevic-liebisch-ph-d-j-d","name":"Ivana Magovevic-Liebisch, Ph.D., J.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:10","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kristina-masson-ph-d-m-b-a","object_label":"Kristina Masson, Ph.D., M.B.A.","object_source_name_forms":[],"value":"Kristina Masson, Ph.D., M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kristina-masson-ph-d-m-b-a","name":"Kristina Masson, Ph.D., M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:11","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-tomsicek-m-b-a","object_label":"Michael Tomsicek, M.B.A.","object_source_name_forms":[],"value":"Michael Tomsicek, M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-tomsicek-m-b-a","name":"Michael Tomsicek, M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:12","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-blume-jensen-m-d-ph-d","object_label":"Peter Blume-Jensen, M.D., Ph.D.","object_source_name_forms":[],"value":"Peter Blume-Jensen, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-blume-jensen-m-d-ph-d","name":"Peter Blume-Jensen, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:13","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:santhosh-palani-ph-d-c-f-a","object_label":"Santhosh Palani, Ph.D., CFA","object_source_name_forms":[],"value":"Santhosh Palani, Ph.D., CFA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:santhosh-palani-ph-d-c-f-a","name":"Santhosh Palani, Ph.D., CFA"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:leadership_role:14","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sharon-shacham-ph-d-m-b-a","object_label":"Sharon Shacham, Ph.D., M.B.A.","object_source_name_forms":[],"value":"Sharon Shacham, Ph.D., M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sharon-shacham-ph-d-m-b-a","name":"Sharon Shacham, Ph.D., M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:15","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Michael Tomsicek, M.B.A.; Members Michael Tomsicek, M.B.A. (Chair); Derek DiRocco, Ph.D.; Ivana Magovevic-Liebisch, Ph.D., J.D.","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Michael Tomsicek, M.B.A.","members":[{"display_name":"Michael Tomsicek, M.B.A.","person_slug":"michael-tomsicek-m-b-a","is_chair":true},{"display_name":"Derek DiRocco, Ph.D.","person_slug":"derek-dirocco-ph-d","is_chair":false},{"display_name":"Ivana Magovevic-Liebisch, Ph.D., J.D.","person_slug":"ivana-magovevic-liebisch-ph-d-j-d","is_chair":false}],"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284","identity_scope":"representation_reference","source_type":"sec_proxy","title":"Audit","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:19","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Charles Baum, M.D., Ph.D.; Members Charles Baum, M.D., Ph.D. (Chair); Santhosh Palani, Ph.D., CFA; Sharon Shacham, Ph.D., M.B.A.","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Charles Baum, M.D., Ph.D.","members":[{"display_name":"Charles Baum, M.D., Ph.D.","person_slug":"charles-baum-m-d-ph-d","is_chair":true},{"display_name":"Santhosh Palani, Ph.D., CFA","person_slug":"santhosh-palani-ph-d-c-f-a","is_chair":false},{"display_name":"Sharon Shacham, Ph.D., M.B.A.","person_slug":"sharon-shacham-ph-d-m-b-a","is_chair":false}],"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284","identity_scope":"representation_reference","source_type":"sec_proxy","title":"Audit","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:470d407f-5f6c-4739-98b3-489250171379:committee_record:23","subject_id":"alpha:company:470d407f-5f6c-4739-98b3-489250171379","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating/Governance: Chair Santhosh Palani, Ph.D., CFA; Members Santhosh Palani, Ph.D., CFA (Chair); Charles Baum, M.D., Ph.D.; Derek DiRocco, Ph.D.","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating/Governance","canonical_type":"nominating_governance","chair":"Santhosh Palani, Ph.D., CFA","members":[{"display_name":"Santhosh Palani, Ph.D., CFA","person_slug":"santhosh-palani-ph-d-c-f-a","is_chair":true},{"display_name":"Charles Baum, M.D., Ph.D.","person_slug":"charles-baum-m-d-ph-d","is_chair":false},{"display_name":"Derek DiRocco, Ph.D.","person_slug":"derek-dirocco-ph-d","is_chair":false}],"source_id":"governance_people_committees"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:12.75153+00:00","sources":[{"id":"alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284","identity_scope":"representation_reference","source_type":"sec_proxy","title":"Audit","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:7bbfae301adc08c5d9a8820a472c28a70e102d15a5cc83f6823825705073b417","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Acrivon Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T20:10:02.508+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:5973f922337b951793b41216af18db98b180d5a8edb1cc88db40da2f71973284","identity_scope":"representation_reference","source_type":"sec_proxy","title":"Audit","publisher":"governance_people_committees","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.826,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.85,"cross_source_agreement":0.75,"temporal_completeness":0.471},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:12.75153+00:00","observed_at":"2026-10-16T13:53:12.75153+00:00","reviewed_at":"2026-10-16T13:53:12.75153+00:00","verified_at":"2026-10-16T13:53:12.75153+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/acrivon-therapeutics-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/acrivon-therapeutics-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}